ResearchIn-Press PreviewImmunology
Open Access |
10.1172/jci.insight.201920
1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America
2Department of Immunology, Mayo Clinic, Phoenix, United States of America
3OverT Bio, New York, United States of America
4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America
6Diabetes Center, UCSF, San Francisco, United States of America
7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom
Find articles by Zanetti, G. in: PubMed | Google Scholar
1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America
2Department of Immunology, Mayo Clinic, Phoenix, United States of America
3OverT Bio, New York, United States of America
4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America
6Diabetes Center, UCSF, San Francisco, United States of America
7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom
Find articles by Nikhat, S. in: PubMed | Google Scholar
1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America
2Department of Immunology, Mayo Clinic, Phoenix, United States of America
3OverT Bio, New York, United States of America
4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America
6Diabetes Center, UCSF, San Francisco, United States of America
7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom
Find articles by Legut, M. in: PubMed | Google Scholar
1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America
2Department of Immunology, Mayo Clinic, Phoenix, United States of America
3OverT Bio, New York, United States of America
4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America
6Diabetes Center, UCSF, San Francisco, United States of America
7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom
Find articles by Chen, A. in: PubMed | Google Scholar
1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America
2Department of Immunology, Mayo Clinic, Phoenix, United States of America
3OverT Bio, New York, United States of America
4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America
6Diabetes Center, UCSF, San Francisco, United States of America
7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom
Find articles by Fathi, F. in: PubMed | Google Scholar
1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America
2Department of Immunology, Mayo Clinic, Phoenix, United States of America
3OverT Bio, New York, United States of America
4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America
6Diabetes Center, UCSF, San Francisco, United States of America
7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom
Find articles by Suek, N. in: PubMed | Google Scholar
1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America
2Department of Immunology, Mayo Clinic, Phoenix, United States of America
3OverT Bio, New York, United States of America
4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America
6Diabetes Center, UCSF, San Francisco, United States of America
7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom
Find articles by Teteloshvili, N. in: PubMed | Google Scholar
1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America
2Department of Immunology, Mayo Clinic, Phoenix, United States of America
3OverT Bio, New York, United States of America
4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America
6Diabetes Center, UCSF, San Francisco, United States of America
7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom
Find articles by Li, H. in: PubMed | Google Scholar
1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America
2Department of Immunology, Mayo Clinic, Phoenix, United States of America
3OverT Bio, New York, United States of America
4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America
6Diabetes Center, UCSF, San Francisco, United States of America
7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom
Find articles by Ding, X. in: PubMed | Google Scholar
1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America
2Department of Immunology, Mayo Clinic, Phoenix, United States of America
3OverT Bio, New York, United States of America
4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America
6Diabetes Center, UCSF, San Francisco, United States of America
7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom
Find articles by
Traum, D.
in:
PubMed
|
Google Scholar
|
1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America
2Department of Immunology, Mayo Clinic, Phoenix, United States of America
3OverT Bio, New York, United States of America
4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America
6Diabetes Center, UCSF, San Francisco, United States of America
7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom
Find articles by
Kaestner, K.
in:
PubMed
|
Google Scholar
|
1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America
2Department of Immunology, Mayo Clinic, Phoenix, United States of America
3OverT Bio, New York, United States of America
4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America
6Diabetes Center, UCSF, San Francisco, United States of America
7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom
Find articles by Hoang, R. in: PubMed | Google Scholar
1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America
2Department of Immunology, Mayo Clinic, Phoenix, United States of America
3OverT Bio, New York, United States of America
4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America
6Diabetes Center, UCSF, San Francisco, United States of America
7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom
Find articles by
Sewell, A.
in:
PubMed
|
Google Scholar
|
1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America
2Department of Immunology, Mayo Clinic, Phoenix, United States of America
3OverT Bio, New York, United States of America
4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America
6Diabetes Center, UCSF, San Francisco, United States of America
7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom
Find articles by Parent, A. in: PubMed | Google Scholar
1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America
2Department of Immunology, Mayo Clinic, Phoenix, United States of America
3OverT Bio, New York, United States of America
4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America
6Diabetes Center, UCSF, San Francisco, United States of America
7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom
Find articles by
Creusot, R.
in:
PubMed
|
Google Scholar
|
1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America
2Department of Immunology, Mayo Clinic, Phoenix, United States of America
3OverT Bio, New York, United States of America
4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America
6Diabetes Center, UCSF, San Francisco, United States of America
7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom
Find articles by
Sykes, M.
in:
PubMed
|
Google Scholar
|
1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America
2Department of Immunology, Mayo Clinic, Phoenix, United States of America
3OverT Bio, New York, United States of America
4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America
5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America
6Diabetes Center, UCSF, San Francisco, United States of America
7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom
Find articles by Khosravi-Maharlooei, M. in: PubMed | Google Scholar
Published November 17, 2026 - More info
Adoptive T-cell therapies using tumour-specific T-cell receptors (TCRs) are limited by competition with endogenous receptors, impairing efficacy and posing risks of off-target autoreactivity. Here we present a CRISPR-based platform that selectively eliminates both endogenous TCR-α and -β chains without affecting transgenic TCRs, irrespective of codon optimization. This approach achieves >90% deletion efficiency in Jurkat and primary human T cells, enhancing expression and functional potency of transgenic receptors. Using an HLA-A*02:01-restricted DMF5 TCR, we show that dual TCR ablation boosts antigen-specific activation and cytotoxicity in vitro and enhances tumor clearance in vivo in human immune system (HIS) mice and prevents graft-versus-host disease (GVHD). Targeted locus amplification showed that CRISPR-induced double-strand breaks did not alter lentiviral integration profiles, supporting genomic safety. Extending this approach to four insulin-reactive TCRs demonstrated that endogenous receptor removal increased transduction efficiency and functional activity, with one (1E6) showing selective activation and infiltration of islet grafts (SC-islets) in vivo. This study establishes a universal, safe, and scalable genome-editing platform for generating functionally precise human T cells. By integrating cancer immunotherapy and autoimmune disease modelling within a single framework, it provides a preclinical rationale for dual endogenous TCR removal to improve specificity, safety, and therapeutic efficacy in TCR-based cell therapies.